AKRIKHIN Ranks in Top Five Employers in Pharmaceutical and Medical Sector in Russia
22.03.2018
AKRIKHIN has ranked in fourth place in the annual 2017 HeadHunter Rating of Employers in Russia in the Pharmaceutics and Medicine category and also placed in the top 100 best employers in Russia.
AKRIKHIN RANKS SECOND IN RUSSIAN PHARMACEUTICAL MARKET INFLUENCE RATING
16.03.2018
AKRIKHIN has ranked second in a Rating of the Influence of Russian Pharmaceutical Market Players in the top 10 Russian pharmaceutical manufacturers that exerted the most influence on the pharmaceutical market in 2017.
MSD AND AKRIKHIN ANNOUNCE SUCCESSFUL LOCALIZATION IN RUSSIA OF MANUFACTURING OF FINISHED DOSAGE FORM OF SITAGLIPTIN FOR TREATING TYPE 2 DIABETES
16.03.2018
MSD, an innovative global pharmaceutical company, and AKRIKHIN, a leading Russian pharmaceutical manufacturer, announced the successful launch of local production of a 100 mg finished dosage form of sitagliptin, an oral anti-hyperglycemic drug for type 2 diabetes.
We use cookies to improve your experience on our site and to show you personalised advertising. By pressing “I AGREE” you accept our cookies policy. To find out more, go to cookies policy.
